Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May-Aug;21(2):211-217.
doi: 10.4103/jomfp.JOMFP_234_16.

Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues using ImageJ analysis with novel immunohistochemistry profiler plugin: An immunohistochemical quantitative analysis

Affiliations

Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues using ImageJ analysis with novel immunohistochemistry profiler plugin: An immunohistochemical quantitative analysis

Deepa Rajesh Mane et al. J Oral Maxillofac Pathol. 2017 May-Aug.

Abstract

Background: Immunohistochemistry (IHC) is a molecular technique that has grown tremendously over the years. However, the assessment is only qualitative which is subjective and causes errors. Due to this limitation, several excellent markers have not gained importance and reached clinical trials. Hence, we aimed to quantify IHC by ImageJ analysis with a novel IHC profiler plugin. ImageJ has not been tried in oral precancerous tissues with minimal attempt for matrix markers.

Aim: This study aimed to validate the quantification of immunoexpression of tenascin-C (TN-C) in oral precancerous tissues and oral squamous cell carcinoma (OSCC) using ImageJ software with IHC profiler plugin.

Materials and methods: After IHC staining for TN-C and image acquisition, ImageJ analysis was performed as per the standard recommended algorithm. Assessment was done by two observers by blinding the histopathological diagnosis. The immunoscore was assessed for interobserver variability using Kohen's kappa statistics.

Results: All our cases were in agreement and found to be statistically significant with P < 0.005. Moderate agreement was for mild dysplasia, moderate dysplasia and oral lichen planus. Substantial agreement was for oral submucous fibrosis and OSCC and almost perfect agreement noted for cases of severe dysplasia.

Conclusion: IHC can now be quantified using freely downloadable software ImageJ analysis in oral precancerous tissues and OSCC. This software with good threshold control can quantify matrix marker such as TN-C. Hence, herewith, we propose that IHC markers should be quantified using ImageJ by our entire oral pathology fraternity so as to have a standard immunoscore for all markers.

Keywords: ImageJ; immunohistochemistry; immunohistochemistry profiler plugin; tenascin-C.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Photomicrograph of the ImageJ software showing immunohistochemistry profiler plugin
Figure 2
Figure 2
Photomicrograph of the ImageJ software showing the selection of “create selection” option
Figure 3
Figure 3
Photomicrograph of the ImageJ software showing the selection of immunohistochemistry profiler macro option
Figure 4
Figure 4
Photomicrograph of immunohistochemistry image of tenascin-C (a), deconvoluted images (b-d), highlighted and selected immunoexpression (e), histogram and log of quantified immunoexpression of tenascin-C in oral epithelial dysplasia (f)
Figure 5
Figure 5
Photomicrograph of immunohistochemistry image of tenascin-C (a), deconvoluted images (b-d), highlighted and selected immunoexpression (e), histogram and log of quantified immunoexpression of tenascin-C in oral lichen planus (f)
Figure 6
Figure 6
Photomicrograph of immunohistochemistry image of tenascin-C (a), deconvoluted images (b-d), highlighted and selected immunoexpression (e), histogram and log of quantified immunoexpression of tenascin-C in oral submucous fibrosis (f)
Figure 7
Figure 7
Photomicrograph of immunohistochemistry image of tenascin-C (a), deconvoluted images (b-d), highlighted and selected immunoexpression (e), histogram and log of quantified immunoexpression of tenascin-C in oral squamous cell carcinoma (f)

References

    1. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577–80. - PubMed
    1. McCarty KS, Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 1986;46(8 Suppl):4244s–8s. - PubMed
    1. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474–81. - PubMed
    1. Taylor CR, Levenson RM. Quantification of immunohistochemistry – Issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49:411–24. - PubMed
    1. Schüffler PJ, Fuchs TJ, Ong CS, Wild PJ, Rupp NJ, Buhmann JM. TMARKER: A free software toolkit for histopathological cell counting and staining estimation. J Pathol Inform. 2013;4:S2. - PMC - PubMed